Anneke Hesseling

13PUBLICATIONS
88CO-AUTHORS
Infant and child healthPharmacogenomicsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 30, 2026
Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35).

|Sep 09, 2026
Pharmacokinetics of Clofazimine Tablet Formulation in Children with Rifampicin-Resistant Tuberculosis in CATALYST, a Multi-Site International Trial.

|Aug 13, 2026
Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis.

|Mar 30, 2026
Clinical Evaluation of Pediatric Pulse Oximeters in South Africa: Protocol for a Cluster Randomized Controlled Trial.

Holly B Schuh, Marieke Van der Zalm, Margaret Van Niekerk

|Jan 08, 2026
Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention.

Ruvarashe J Madzime, Louvina van der Laan, Samantha du Toit

|Dec 28, 2024
Model-Informed Once-Daily Dosing Strategy for Bedaquiline and Delamanid in Children, Adolescents and Adults with Tuberculosis.

Yu-Jou Lin, Louvina E van der Laan, Mats O Karlsson

Pageof 3

Frequent Collaborators

6 joint publications

Louvina van der Laan

5 joint publications

Anthony J Garcia-Prats

3 joint publications

Belen Solans

3 joint publications

Megan Palmer